Diabetic Retinopathy. Macular edema?

Searching the Internet... Opinion: Both Lucentis (ranibizumab) and Eylea (aflibercept) are anti-VEGF (vascular endothelial growth factor) medications used for the treatment of Diabetic Macular Edema (DME). These medications work by inhibiting the growth of abnormal blood vessels and reducing fluid leakage in the macula, which can improve vision in patients with DME. Next steps: 1. Consult with an ophthalmologist: It is important to consult with an ophthalmologist who specializes in the treatment of retinal conditions, such as DME. They will be able to evaluate your specific case and recommend the most appropriate treatment option for you. 2. Discuss the options: During your consultation, discuss the differences between Lucentis and Eylea with your ophthalmologist. They will explain the benefits, potential side effects, and any other relevant factors to help you make an informed decision. 3. Follow the recommended treatment plan: Once you and your ophthalmologist have decided on the most suitable medication, follow the prescribed treatment plan. Attend regular follow-up appointments to monitor your progress and make any necessary adjustments to your treatment. Remember, every individual's case is unique, and the choice of medication may vary based on factors such as the severity of DME, response to treatment, and individual patient characteristics. Your ophthalmologist will guide you through the decision-making process and provide the best care for your specific needs.